Tango Therapeutics TNGX Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Tango Therapeutics's compensation and benefits?
- Tango Therapeutics (TNGX) reported compensation and benefits of $3.24M in Q1 2026.
- How has Tango Therapeutics's compensation and benefits changed year-over-year?
- Tango Therapeutics's compensation and benefits increased by 1.9% year-over-year, from $3.18M to $3.24M.
- What is the long-term trend for Tango Therapeutics's compensation and benefits?
- Over 5 years (2020 to 2025), Tango Therapeutics's compensation and benefits has grown at a 27.8% compound annual growth rate (CAGR), from $2.65M to $9.05M.